Beta Bionics Inc., which makes ­a “bionic pancreas,” has secured $60 million in a Series E funding round led by new investor ...
DexCom Inc (DXCM) stock saw a decline, ending the day at $77.72 which represents a decrease of $-1.20 or -1.52% from the prior close of $78.92. The stock opened at $79.21 and touched a low of $77.33 ...
OK, I've been a little late coming up with my holiday gift guide, as we've already passed both Black Friday and Cyber Monday.
Shares of DexCom Inc. DXCM slipped 1.52% to $77.72 Friday, on what proved to be an all-around mixed trading session for the ...
DexCom Inc (DXCM) stock saw a decline, ending the day at $78.92 which represents a decrease of $-2.09 or -2.58% from the prior close of $81.01. The stock opened at $80.91 and touched a low of $78.06 ...
Connacht head coach Pete Wilkins has named his side for tomorrow’s EPCR Challenge Cup opener with Zebre Parma at Dexcom ...
The stock's fall snapped a three-day winning streak.
Glucose Sensor Market. The global glucose sensor market is projected to witness substantial growth, reaching a valuation of ...
Johnson Fistel, LLP investigates potential violations of federal and state laws by certain officers of several publicly traded companies, including DexCom, Inc.
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $90.00. The ...
Continuous glucose monitoring (CGM) for healthy people is becoming big business — and 2024 has been a huge year. Abbott Lingo ...
The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...